Corporate Tax Inversions: Treasury Department's New Rules Won't Stop Company Deals Designed To Avoid US Taxes

When the U.S. Department of the Treasury released new rules concerning corporate tax inversions Thursday, all eyes settled on Pfizer. The pharmaceutical giant and Viagra maker is in talks to acquire Dublin-based Allergan. The move would allow Pfizer to headquarter in low-tax Ireland, relieving the company of what chief executive Ian Read has called the "tremendous disadvantage" of U.S. corporate taxes.